Opin vísindi

The economic consequences of attention-deficit hyperactivity disorder in the Scottish prison system

Skoða venjulega færslu

dc.contributor Reykjavík University (RU)
dc.contributor Háskólinn í Reykjavík (HR)
dc.contributor.author Young, Susan
dc.contributor.author González, Rafael A.
dc.contributor.author Fridman, Moshe
dc.contributor.author Hodgkins, Paul
dc.contributor.author Kim, Keira
dc.contributor.author Gudjonsson, Gisli H.
dc.date.accessioned 2019-11-22T15:15:05Z
dc.date.available 2019-11-22T15:15:05Z
dc.date.issued 2018-06-25
dc.identifier.citation Young, S., González, R. A., Fridman, M., Hodgkins, P., Kim, K. og Gudjonsson, G. H. (2018). The economic consequences of attention-deficit hyperactivity disorder in the Scottish prison system. BMC Psychiatry, 18(1), 210. doi:10.1186/s12888-018-1792-x
dc.identifier.issn 1471-244X
dc.identifier.uri https://hdl.handle.net/20.500.11815/1353
dc.description.abstract Background: Attention-deficit hyperactivity disorder (ADHD) is highly prevalent amongst prison inmates and the criminal justice system (CJS) likely bears considerable costs for offenders with ADHD. We aimed to examine the relationship between ADHD and health-related quality of life (HRQoL) and quality-adjusted life years (QALY) amongst imprisoned adults; and to estimate the annual expenditure associated with ADHD status in prison. Methods: An observational study was performed in 2011–2013, at Porterfield Prison, Inverness, United Kingdom (UK). The all male sample included 390 adult prison inmates with capacity to consent and no history of moderate or severe intellectual disability. Participants were interviewed using the Diagnostic Interview for ADHD in Adults 2.0. The Health Utilities Index Mark 3 (HUI3) was used to measure health status, and to calculate attribute specific HRQoL scores and QALY. Health service utilisation was obtained through inspection of medical prison records. Inmates with ADHD were compared with inmates without ADHD. Results: Inmates with ADHD had significantly lower QALYs, with a clinically significant adjusted difference of 0.13. Psychiatric co-morbidity accounted for the variation of ADHD on the HUI3 emotion domain only. Medical costs for inmates with ADHD were significantly higher; and behaviour-related prison costs were similar to prisoners without ADHD, reflecting a low frequency of recorded critical incidents. Conclusions: ADHD may directly contribute to adverse health and quality of life through cognitive and executive function deficits, and co-morbid disorders. The extrapolation of conservative cost estimates suggests that the financial burden of medical and behavior-related prison care for inmates with ADHD in the UK is approximately £11.7 million annually. The reported cost estimates are conservative as there is great variability in recorded critical incidents in prisons. In turn, for some prison establishments the prison care costs associated with prisoners with ADHD may be considerably greater.
dc.description.sponsorship The study was supported by Shire Pharmaceutical Development Limited through a restricted grant. Shire had no role in the design and conduct of the study (collection, management, analysis, and interpretation of the data) or on the preparation, review, or approval of the manuscript, and the decision to submit the manuscript for publication. The research was also supported by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre
dc.format.extent 210
dc.language.iso en
dc.publisher Springer Science and Business Media LLC
dc.relation.ispartofseries BMC Psychiatry;18(1)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Psychiatry and Mental health
dc.subject ADHD
dc.subject Health-related quality of life
dc.subject Economic evaluation
dc.subject Quality-adjusted life years
dc.subject Prison
dc.subject Costs
dc.subject Fangelsisvist
dc.subject Fangelsi
dc.subject Lífsgæði
dc.subject Sálfræði
dc.subject Psychology
dc.title The economic consequences of attention-deficit hyperactivity disorder in the Scottish prison system
dc.type info:eu-repo/semantics/article
dcterms.license © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).
dc.description.version Peer Reviewed (ritrýnd grein)
dc.identifier.journal BMC Psychiatry
dc.identifier.doi https://doi.org/10.1186/s12888-018-1792-x
dc.contributor.school Viðskiptadeild (HR)
dc.contributor.school School of Business (RU)


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu